For patients hospitalized for acute heart failure, treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin produces clinical benefit, according to a study published online April 4 in Circulation ...
Apr 13, 2022
0
9
Children and adolescents (aged 0-18 years) with disability experience physical, sexual, and emotional violence, and neglect at considerably higher rates than those without disability, despite advances in awareness and policy ...
Mar 18, 2022
0
4
A simple balance and gait assessment many therapists and athletic trainers use to detect subtle impairments in children and teens who have sustained a concussion may help identify whether they are ready to return to normal ...
Feb 1, 2022
0
12
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature ...
Nov 30, 2021
0
55
Women between the ages of 18-44 who reported having some type of disability, such as those related to cognition and activities of daily life, reported low diet healthfulness and low levels of food security when compared to ...
Nov 8, 2021
0
1
(HealthDay)—Almost one-quarter of U.S. adults report arthritis, according to research published in the Oct. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Oct 8, 2021
0
2
When COVID-19 patients are discharged from the hospital, most are far from being well—even if their hospital stay was fairly short.
Aug 25, 2021
0
126
Findings from a study on the feasibility of addressing anxiety, pain and stress with Olfactory Virtual Reality (OVR)—a new form of VR that incorporates the sense of smell into its augmented reality—paint a clearer picture ...
Jun 14, 2021
0
2
A study by the Faculty of Physiotherapy of the University of Valencia (UV), in collaboration with the Autonomous University of Madrid, has shown that a physiotherapy program that uses the Nintendo Wii console improves the ...
Jun 9, 2021
0
6
Cleveland Clinic researchers leading a global clinical trial have found that rilonacept, an FDA approved drug for other inflammatory diseases, resolved acute pericarditis episodes and reduced risk of pericarditis recurrence. ...
Nov 17, 2020
0
2
